Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNapoli, Italy was updated to Naples, Italy in the locations list.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 on the page.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior operating-status notice along with Revision: v3.4.1.SummaryDifference0.5%

- Check61 days agoChange DetectedIntroduced a site-wide notice about potential information delays due to a lapse in government funding and where to check operating status. A new Revision: v3.4.1 tag was added and Revision: v3.4.0 was removed.SummaryDifference0.5%

- Check68 days agoChange DetectedShow glossary was added, and several UI/metadata labels were updated (e.g., capitalization of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a new 'Revision: v3.4.0' note in the footer. The previous labels were 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.